Drug intelligence / Profile preview

ephrin A5-Fc

Development stage
Preclinical
Lead developer
QIMR Berghofer Medical Research Institute
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intratumoral
01

Overview

ephrin A5-Fc is a recombinant fusion protein consisting of the extracellular domain of the ephrin-A5 ligand fused to the Fc region of human IgG. It functions as a high-affinity ligand for the Eph family of receptor tyrosine kinases, with a particular focus on EphA3, which is frequently overexpressed in glioblastoma (GBM). By binding to and activating EphA3, ephrin A5-Fc triggers the ERK/MAPK signaling pathway, which induces the differentiation of cancer stem cells and reduces tumor cell proliferation. In preclinical research, it has demonstrated the ability to attenuate tumor growth and prevent the formation of invasive intracranial xenografts. While primarily utilized as a research tool to study cell adhesion, migration, and axon guidance, its potential to modulate oncogenic signaling in aggressive brain tumors has made it a subject of therapeutic investigation.

Other names
ephrin-A5-Fcephrin-A-5-Fcephrin-A 5-Fcephrin-A5-IgG Fcephrin-A-5-IgG Fcephrin-A 5-IgG Fcrecombinant human ephrin-A5 Fc chimera
02

Targets

EPHA4EPHB2 (Ephrin type-B receptor 2)EPHA2 (Ephrin type-A receptor 2)EPHA3 (Ephrin Receptor A3)

Beyond the preview

Go deeper on ephrin A5-Fc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ephrin A5-Fc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call